Clinical Trial Update: PSMA PET Response Guided SabR in High Risk Pca [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating PSMA PET response-guided SABR in high-risk prostate cancer, currently recruiting at UT Southwestern Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Prostate Adenocarcinoma | Phase 1 | Status: RECRUITING